Existing Grants. The Parties further acknowledge and agree that pursuant to the Cross-License Agreement, Medarex has granted a non-exclusive license under certain Medarex Patents to Exploit Antibody Products, including Collaboration Products, `With respect to Antigens, including the Collaboration Targets, in the Territory.
Appears in 3 contracts
Samples: Collaboration Agreement (Northwest Biotherapeutics Inc), Collaboration Agreement (Northwest Biotherapeutics Inc), Collaboration Agreement (Northwest Biotherapeutics Inc)
Existing Grants. The Parties further acknowledge and agree that pursuant to the Cross-License Agreement, Medarex has granted a non-exclusive license under certain Medarex Patents to Exploit Antibody Products, including Collaboration Products, `With with respect to Antigens, including the Collaboration Targets, in the Territory.
Appears in 2 contracts
Samples: Collaboration Agreement (Seattle Genetics Inc /Wa), Collaboration Agreement (Seattle Genetics Inc /Wa)
Existing Grants. The Parties further acknowledge and agree that (a) pursuant to the Cross-License Agreement, Medarex has granted a non-exclusive license under certain Medarex Patents to Exploit Antibody Products, including Collaboration Products, `With with respect to Antigens, including the Collaboration TargetsTarget, in the Territory; and (b) pursuant to certain existing agreements with Third Parties, Medarex has granted exclusive rights under the Medarex Technology to Exploit Antibody Products with respect to Antigens other than the Collaboration Target, which Antibody Products could be the same as Collaboration Products.
Appears in 1 contract
Samples: Collaboration Agreement (Healthcare Acquisition Corp)
Existing Grants. The Parties further acknowledge and agree that pursuant to the Cross-License Agreement, Medarex has granted a non-exclusive license under certain Medarex Patents to Exploit Antibody Products, including Collaboration Products, `With Products with respect to Antigens, including the Collaboration Unilateral Targets, in the Territory.
Appears in 1 contract
Samples: Collaboration Agreement (Northwest Biotherapeutics Inc)
Existing Grants. The Parties further acknowledge and agree that (a) pursuant to the Cross-License Agreement, Medarex has granted a non-exclusive license under certain Medarex Patents to Exploit Antibody Products, including Collaboration Products, `With Products with respect to Antigens, including the Collaboration Unilateral Targets, in the Territory, and (b) Medarex has entered into a Research and Commercialization Agreement with Genmab.
Appears in 1 contract
Existing Grants. The Parties further acknowledge and agree that (a) pursuant to the Cross-License Agreement, Medarex has granted a non-exclusive license under certain Medarex Patents to Exploit Antibody Products, including Collaboration Products, `With with respect to Antigens, including the Collaboration Targets, in the Territory, and (b) Medarex has entered into a Research and Commercialization Agreement with Genmab.
Appears in 1 contract
